You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – MapKure announced a partnership with Personalis on Monday to use its NGS assay, the NeXT Platform, to screen patients for a Phase I clinical trial of its BRAF inhibitor, BGB-3245.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.